Inverness Medical Introduces New Portable Blood Testing Device
Inverness Medical Physician Diagnostics Group, a division of Inverness Medical Innovations, has launched the INRatio2 PT/INR monitoring system, a portable device that measures blood-clotting time, also known as prothrombin time, using one drop of blood from a patient’s finger.
The INRatio2 is used by healthcare professionals and their patients in the management of warfarin, a blood-thinning drug, to monitor the effectiveness of the drug and warn of potential blood clots and other bleeding risks, the company said.
According to the company, the INRatio2 offers many patient-friendly features, including a one-minute test time, easy single button interface, and 200 test battery life. Its simple fingerstick test procedure, light weight (9.3 ounce), and individually sealed test strip packaging enables patients to easily test themselves at home or when traveling, the company added.
The INRatio2 PT/INR monitoring system has been cleared by the FDA for warfarin patients to test themselves at home, offering patients quick access to their PT/INR results. The test results are then transmitted to their treating physician by telephone or internet. The results provide important data that helps physicians make informed warfarin dosing adjustments to ensure that patients stay within their recommended therapeutic range.
David Phillips, vice president of marketing for Inverness Medical’s coagulation division, said: “Due to Medicare’s expanded coverage of home INR monitoring for atrial fibrillation and venous thromboembolism earlier in 2008, the INRatio2 is now accessible to more patients who wish to monitor their own coagulation.”